Literature DB >> 22064408

Targeting osteoclast-osteoblast communication.

Xu Cao.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22064408     DOI： 10.1038/nm.2499

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

1.  Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment.

Authors:  Rowena McBeath; Dana M Pirone; Celeste M Nelson; Kiran Bhadriraju; Christopher S Chen
Journal:  Dev Cell       Date:  2004-04       Impact factor: 12.270

Review 2.  Skeletal remodeling in health and disease.

Authors:  Mone Zaidi
Journal:  Nat Med       Date:  2007-07       Impact factor: 53.440

Review 3.  Osteonecrosis of the jaw: who gets it, and why?

Authors:  Ian R Reid
Journal:  Bone       Date:  2008-10-07       Impact factor: 4.398

4.  Inhibition of Sca-1-positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling.

Authors:  Xiangwei Wu; Lijuan Pang; Weiqi Lei; William Lu; Jun Li; Zhaoyang Li; Frank J Frassica; Xueling Chen; Mei Wan; Xu Cao
Journal:  Cell Stem Cell       Date:  2010-11-05       Impact factor: 24.633

5.  Suppression of bone formation by osteoclastic expression of semaphorin 4D.

Authors:  Takako Negishi-Koga; Masahiro Shinohara; Noriko Komatsu; Haruhiko Bito; Tatsuhiko Kodama; Roland H Friedel; Hiroshi Takayanagi
Journal:  Nat Med       Date:  2011-10-23       Impact factor: 53.440

6.  Smad3 regulates Rho signaling via NET1 in the transforming growth factor-beta-induced epithelial-mesenchymal transition of human retinal pigment epithelial cells.

Authors:  Jungeun Lee; Hyun-Jeong Moon; Jong-Min Lee; Choun-Ki Joo
Journal:  J Biol Chem       Date:  2010-06-11       Impact factor: 5.157

7.  An estimate of the worldwide prevalence and disability associated with osteoporotic fractures.

Authors:  O Johnell; J A Kanis
Journal:  Osteoporos Int       Date:  2006-09-16       Impact factor: 4.507

8.  Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling.

Authors:  A Kumanogoh; C Watanabe; I Lee; X Wang; W Shi; H Araki; H Hirata; K Iwahori; J Uchida; T Yasui; M Matsumoto; K Yoshida; H Yakura; C Pan; J R Parnes; H Kikutani
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

Review 9.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

Review 10.  Bisphosphonates: mechanism of action and role in clinical practice.

Authors:  Matthew T Drake; Bart L Clarke; Suneep Khosla
Journal:  Mayo Clin Proc       Date:  2008-09       Impact factor: 7.616
View more
  39 in total

1.  Humanized culture of periosteal progenitors in allogeneic serum enhances osteogenic differentiation and in vivo bone formation.

Authors:  Scott J Roberts; Helen C Owen; Wai Long Tam; Lien Solie; Sophie J Van Cromphaut; Greet Van den Berghe; Frank P Luyten
Journal:  Stem Cells Transl Med       Date:  2013-12-27       Impact factor: 6.940

2.  Demethoxycucumin protects MDA-MB-231 cells induced bone destruction through JNK and ERK pathways inhibition.

Authors:  Xiaofeng Shen; Xiaochen Sun; Hua Chen; Binjie Lu; Yuanyuan Qin; Chenxi Zhang; Guoqiang Liang; Jiangping Wang; Pengfei Yu; Li Su; Qihan Ma; Yuwei Li
Journal:  Cancer Chemother Pharmacol       Date:  2021-01-05       Impact factor: 3.333

3.  Role of inhibition of osteogenesis function by Sema4D/Plexin-B1 signaling pathway in skeletal fluorosis in vitro.

Authors:  Xiao-Li Liu; Jing Song; Ke-Jian Liu; Wen-Peng Wang; Chang Xu; Yu-Zeng Zhang; Yun Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

4.  miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.

Authors:  Chenyang Zhao; Weijia Sun; Pengfei Zhang; Shukuan Ling; Yuheng Li; Dingsheng Zhao; Jiang Peng; Aiyuan Wang; Qi Li; Jinping Song; Cheng Wang; Xiaolong Xu; Zi Xu; Guohui Zhong; Bingxing Han; Yan-Zhong Chang; Yingxian Li
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

5.  Modification of the RANKL-RANK-binding site for the immunotherapeutic treatment of osteoporosis.

Authors:  Y Ko; G Lee; B Kim; M Park; Y Jang; W Lim
Journal:  Osteoporos Int       Date:  2019-12-20       Impact factor: 4.507

6.  Resolvin E1 regulates osteoclast fusion via DC-STAMP and NFATc1.

Authors:  Min Zhu; Thomas E Van Dyke; Robert Gyurko
Journal:  FASEB J       Date:  2013-04-29       Impact factor: 5.191

7.  Groove structure of porous hydroxyapatite scaffolds (HAS) modulates immune environment via regulating macrophages and subsequently enhances osteogenesis.

Authors:  Chenglong Li; Lu Yang; Xiaohua Ren; Mu Lin; Xiliang Jiang; Daonan Shen; Taotao Xu; Jing Ren; Lijuan Huang; Wei Qing; Jiajun Zheng; Yandong Mu
Journal:  J Biol Inorg Chem       Date:  2019-07-19       Impact factor: 3.358

8.  Quantitative characterization of mineralized silk film remodeling during long-term osteoblast-osteoclast co-culture.

Authors:  Rebecca S Hayden; Kyle P Quinn; Carlo A Alonzo; Irene Georgakoudi; David L Kaplan
Journal:  Biomaterials       Date:  2014-01-29       Impact factor: 12.479

9.  Critical role of filamin-binding LIM protein 1 (FBLP-1)/migfilin in regulation of bone remodeling.

Authors:  Guozhi Xiao; Hongqiang Cheng; Huiling Cao; Ka Chen; Yizeng Tu; Shibing Yu; Hongli Jiao; Shengyong Yang; Hee-Jeong Im; Di Chen; Ju Chen; Chuanyue Wu
Journal:  J Biol Chem       Date:  2012-05-03       Impact factor: 5.157

Review 10.  Targeting TGFβ signaling in subchondral bone and articular cartilage homeostasis.

Authors:  Gehua Zhen; Xu Cao
Journal:  Trends Pharmacol Sci       Date:  2014-04-15       Impact factor: 14.819
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.